Geron Patent definition

Geron Patent means a Patent which claims a process, method, apparatus, composition of matter, compound, chemical, material, or article of manufacture useful in the Field (or the discovery, development, manufacture and clinical use of compounds having potential activity in the Field), which Patent is Controlled by Geron or its Affiliates during the term of this Agreement, including Geron's undivided interest in any Patent jointly owned with KH or P&U.
Geron Patent means a Patent which claims a process, method, apparatus, composition of matter, compound, chemical, material, or article of manufacture useful in the Field (or the discovery, development, manufacture and clinical use of compounds having * Certain portions of this Exhibit have been omitted for which confidential treatment has been requested and filed separately with the Securities and Exchange Commission. 6 potential activity in the Field), which Patent is Controlled by Geron or its Affiliates during the term of this Agreement, including Geron's undivided interest in any Joint Patent. Set forth in EXHIBIT 1.12 is a list of all current Geron Patents.

Examples of Geron Patent in a sentence

  • Should Geron determine not to file, prosecute, issue or maintain a Geron Patent or Joint Patent in the Field, it will timely grant any necessary authority it may legally grant to P&U to file, prosecute, issue or maintain such Patent in the name of Geron in the Field, all at the expense of P&U.

  • Geron Patent which it receives as a patent owner pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984 (hereinafter called the "Act"), including but not limited to notices pursuant to Section Section 101 and 103 of the Act from persons who have filed an abbreviated NDA ("ANDA").

  • Section 13.4 of the KH Agreement is hereby amended to provide that the right to institute, prosecute and control any action or proceeding with respect to the infringement or defense of a Geron Patent, Kyowa Hakko Patent or Joint Patent relating to a Product shall be as provided in the Three-Way Agreement.

  • In the event Geron does not want to file, prosecute, or maintain a Geron Patent or Joint Patent due to cost considerations, then BMG shall have the right to request that such Geron Patent be filed, prosecuted, or maintained, and BMG shall pay the Patent Costs associated therewith and shall have the right to control such filing, prosecution, or maintenance at its sole discretion thereafter.

  • Notwithstanding the non-exclusive nature of such license, in order to preserve the exclusive nature of Merck’s option pursuant to Section 3.2.3, Geron shall not grant any license in the Territory to any Third Party under Geron Patent Rights, Geron Know-How, Geron Program Patent Rights, Geron’s interest in Joint Program Patent Rights or Geron’s interest in Program Know-How to develop or commercialize DC Products, DC/Non-DC Therapies or DC/Adeno/DNA Therapies in the Field during such *-year period.

  • In particular, Geron shall consult with Merck and consider Merck’s suggestions regarding countries where such Geron Patent Rights shall be filed.

  • All final decisions with respect to filing, prosecution and maintenance of Geron Patent Background Rights and Geron Future Patent Rights shall be made by Geron.

  • PATENT PROVISIONS 8.1 Geron Patent Rights 8.2 Licensed Program Patent Rights 8.3 Patent Term Restoration 9.

  • Within five (5) business days of receipt of such certification, Geron shall provide Merck with a copy of such certification and Geron shall timely inform Merck if it elects not to exercise such first right and, subject to any other obligations of Geron existing as of the Effective Date, Merck shall thereafter have the right to initiate and prosecute such action to terminate infringement, of Geron Patent Rights, or misappropriation or misuse of Geron Know-How in the names of Merck and, if necessary, Geron.

  • Geron shall provide Merck with periodic updates on prosecution of Geron Patent Rights relevant to the Field and shall cooperate with Merck with respect to strategies for securing patent protection for the Field.

Related to Geron Patent

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Patent Rights means all patents and patent applications, including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, reissues, additions, renewals, extensions, registrations, and supplemental protection certificates and the like of any of the foregoing.

  • Patent Right means: (a) an issued or granted patent, including any extension, supplemental protection certificate, registration, confirmation, reissue, reexamination, extension or restoration by existing or future extension or restoration mechanisms (including, without limitation, supplementary protection certificates or the equivalent thereof), or renewal thereof; (b) a pending patent application, including any continuation, divisional, continuation-in-part, substitute or provisional application thereof; and (c) all counterparts or foreign equivalents of any of the foregoing issued by or filed in any country or other jurisdiction.

  • Licensed Patent means Stanford's rights in U.S. Patent Application, Serial Number , filed , any foreign patent application corresponding thereto, and any divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP) patent application or patent.

  • Program Patents has the meaning set forth in Section 7.1.2.

  • Program Patent Rights means any Patent Rights that contain one or more claims that cover Program Inventions.

  • Joint Patent Rights means Patent Rights that contain one or more claims that cover Joint Technology.

  • Licensed Patent Rights means: (a) Patent applications (including provisional patent applications and PCT patent applications) or patents listed in Appendix A, all divisions and continuations of these applications, all patents issuing from these applications, divisions, and continuations, and any reissues, reexaminations, and extensions of these patents; (b) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): (i) continuations-in-part of 2.9(a); (ii) all divisions and continuations of these continuations-in-part; (iii) all patents issuing from these continuations-in-part, divisions, and continuations; (iv) priority patent application(s) of 2.9(a); and (v) any reissues, reexaminations, and extensions of these patents; (c) to the extent that the following contain one or more claims directed to the invention or inventions disclosed in 2.9(a): all counterpart foreign and U.S. patent applications and patents to 2.9(a) and 2.9(b), including those listed in Appendix A; and (d) Licensed Patent Rights shall not include 2.9(b) or 2.9(c) to the extent that they contain one or more claims directed to new matter which is not the subject matter disclosed in 2.9(a).

  • Licensed Patents means (a) all United States patents and patent applications listed in Exhibit A, as modified pursuant to Section 2.6.1, including patents arising from such patent applications; and (b) any re-examination certificates thereof, and their foreign counterparts and extensions, continuations, divisionals, and re-issue applications; provided that “Licensed Patents” will not include any claim of a patent or patent application covering any Manufacturing Technology.

  • Joint Patent means a patent that issues from a Joint Patent Application.

  • Product Patents means any and all United States patents and patent applications, all divisionals, continuations, continuations-in-part, re-issues, extensions or foreign counterparts thereof, now or hereafter owned or controlled ("controlled" being used in the sense of having the right to grant licenses thereunder) by PERIMMUNE, covering the manufacture, use, sale, offer for sale and/or importation of the Product, including but not limited to, the U.S. Patent No. 5,407,912 attached hereto as Exhibit B.

  • Licensee Patents means any Patents within the Control of Licensee as of the Effective Date and at any time during the Term relating to the Product.

  • Joint Patents means all Patents claiming any Joint Invention.

  • Company Patents means Patents owned by the Company or used or held for use by the Company in the Business.

  • Regents' Patent Rights means REGENTS' rights in (a) the patent and patent applications expressly identified in Appendix C and their foreign counterparts;

  • Valid Patent Claim means a claim of the Licensed Patents that has not lapsed or become abandoned or been declared invalid or unenforceable by a court or agency of competent jurisdiction from which no appeal can be or is taken.

  • Existing Patents has the meaning set forth in Section 10.2.1.

  • Assigned Patent Rights means all of the following, whether now owned or hereafter acquired or arising:

  • Patent means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisionals, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.

  • Valid Claims means Settlement Claims in an amount approved by the Claims Administrator or found to be valid through the claims processing and/or Dispute Resolution process.

  • Valid Claim means a claim of an issued and unexpired Patent that (i) has not been revoked or held unenforceable or invalid by a decision of a court or other Governmental Entity of competent jurisdiction from which no appeal can be taken or has been taken within the time allowed for appeal and (ii) has not been abandoned, disclaimed, denied, or admitted to be invalid or unenforceable through reissue or disclaimer or otherwise in such country.

  • Assigned Patents means all Patents issued to, or for which applications are pending in the name of, Holdings or any of its Subsidiaries and (a) assigned to IP Hold-Co in accordance with the Patent Assignment Agreement, including without limitation any Patents described on Schedule 5.17(a) or that are thereafter acquired by, or filed in the name of, Holdings or any of its Subsidiaries, including Patents that are the subject of Section 6.18.

  • Patent Family means all patents and patent applications that share a common priority application, excluding continuations in part, but including any divisionals, continuations, reissues, reexaminations, extensions, foreign counterparts or equivalents. For the avoidance of doubt, if any patent or patent application is subject to a terminal disclaimer with any other patent or patent application such patent or patent application and such other patent or patent application shall be deemed one (1) Patent Family for the purposes of this Agreement.

  • Patent Application means an application for patent protection for a CRADA Subject Invention with the United States Patent and Trademark Office (“U.S.P.T.O.”) or the corresponding patent-issuing authority of another nation.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.